Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 4,875,600 | 4,935,600 | 4,683,100 | 5,808,800 | 5,772,600 |
| Cost of Goods | 1,267,000 | 1,189,700 | 1,222,700 | 1,386,500 | 1,198,100 |
| Gross Profit | 3,608,600 | 3,745,900 | 3,460,400 | 4,422,300 | 4,574,500 |
| Operating Expenses | 3,010,300 | 2,860,000 | 2,594,900 | 3,543,699 | 3,029,900 |
| Operating Income | 598,300 | 886,600 | 866,200 | 879,100 | 1,544,700 |
| Other Income | 57,200 | 53,800 | 24,600 | 30,800 | -31,300 |
| Pre-tax Income | 655,500 | 940,400 | 890,800 | 909,900 | 1,513,400 |
| Income Tax | 154,900 | 206,900 | 162,900 | 182,400 | 310,300 |
| Net Income Continuous | 500,600 | 733,500 | 727,900 | 727,500 | 1,203,100 |
| Net Income | $500,600 | $733,500 | $727,900 | $727,500 | $1,203,100 |
| EPS Basic Total Ops | 0.47 | 0.68 | 0.68 | 0.68 | 1.11 |
| EPS Basic Continuous Ops | 0.47 | 0.68 | 0.68 | 0.68 | 1.11 |
| EPS Diluted Total Ops | 0.47 | 0.68 | 0.68 | 0.68 | 1.11 |
| EPS Diluted Continuous Ops | 0.47 | 0.68 | 0.68 | 0.68 | 1.11 |
| EBITDA(a) | $940,700 | $1,235,000 | $1,215,000 | $1,230,301 | $1,893,700 |